Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
NGO

City of Hope

Tracked across 9 events · 153 articles · First seen Apr 07, 2026 · Last active Sep 24, 2026

Sentiment
19
Attention
7
Events
9
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 30
Tech
Researchers led by City of Hope developed an investigational liquid biopsy called PANXEON that could detect pancreatic cancer at its earliest, potentially curable stages. The large international study, published in Nature Medicine, tested the blood…
Impact: City of Hope led the development of the PANXEON blood test and the international study, reinforcing its position as a leading cancer research and treatment organization.
Sep 16, 2026 · 6 articles
4 60
Tech
PeproMene Bio announced the publication in The Lancet of results from its Phase 1 clinical trial of PMB-CT01, a first-in-class BAFF-R-targeted CAR T-cell therapy, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma. The trial…
Impact: City of Hope is the coordinating center and manufacturing site for the trial and has licensed IP to PeproMene Bio. The success enhances its reputation in cancer research and may lead to further collaborations and licensing revenue.
Jul 20, 2026 · 6 articles
6 65
Tech
Impact: City of Hope>>> is a national cancer research and treatment organization that conducts trials for new drugs and focuses on understanding the journey of cancer survivors.
Jun 03, 2026 · 6 articles
7 10
Regulatory
Impact: City of Hope's Pashtoon Kasi commented that the drug is the best option ever for pancreatic cancer patients, though not a cure, and predicted it will open doors for other companies.
Aug 26, 2026 · 92 articles
4 0
Regulatory
An advisory committee to the United States — Food and Drug Administration voted on Wednesday to recommend approval of Grail Inc.'s Galleri blood test, the first multi-cancer early detection test to reach this stage of…
Impact: Its researchers provided expert commentary supporting the test's potential and the broader early-detection field.
Sep 23, 2026 · 18 articles
4 5
Tech
The United States — Food and Drug Administration approved daraxonrasib, a first-of-its-kind daily pill for metastatic pancreatic cancer, sold by Revolution Medicines under the brand name Rasonque. The drug blocks mutated KRAS proteins that drive…
Impact: Its researcher said the approval opens doors for other companies, highlighting spillover interest in KRAS therapies.
Aug 26, 2026 · 6 articles
3 0
Tech
Impact: Kristin Higgins from City of Hope commented on the study, urging caution.
Jul 13, 2026 · 6 articles
4 0
Business
Apr 07, 2026 · 7 articles
4 0
Tech
Apr 23, 2026 · 6 articles
ERGEN INTELLIGENCE
Track City of Hope live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.